Pharma-Bio Serv, Inc. (PBSV) Stock Price & Analysis
Pharma-Bio Serv, Inc. (PBSV) fell 7.82% to USD 0.53 as of June 10, 2026 at 04:03 UTC, according to Nexqual real-time market data.
PBSV last closed at USD 0.57; the session ranged USD 0.53–0.53 on volume of 1,025 shares. Market capitalization is $12.03M, with a 52-week range of USD 0.43–1.36 (OQB). Source: Nexqual, June 10, 2026 at 04:03 UTC.
Key Statistics (as of June 10, 2026 at 04:03 UTC)
| Price | USD 0.53 |
|---|---|
| Change | ▼ 7.82% (down) |
| Previous Close | USD 0.57 |
| Open | USD 0.53 |
| Day Range | USD 0.53 – 0.53 |
| 52-Week Range | USD 0.43 – 1.36 |
| Volume | 1,025 shares |
| Market Cap | $12.03M |
| Exchange | OQB |
Technical Analysis (PBSV)
Nexqual's technical model rates PBSV "NEUTRAL" based on 3 bullish and 3 bearish signals across 123 daily candles, as of June 10, 2026 at 04:03 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 43.14 (neutral) |
| vs SMA50 | Above (USD 0.53) |
| MACD | 0.01 (positive) |
Analyst Ratings (PBSV)
Wall Street analysts rate PBSV "None" based on 1 analysts, with a mean price target of USD 1.5 (range USD 1.5–1.5), per Nexqual as of June 10, 2026 at 04:03 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 1.5 |
| High Target | USD 1.5 |
| Low Target | USD 1.5 |
| Buy / Hold / Sell | 0 / 0 / 0 |
Earnings (PBSV)
| EPS Estimate | USD 0.03 |
|---|---|
| Revenue Estimate | $2.50M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-01-31 | USD 0 vs est 0.02 ▼ miss |
| 2025-10-31 | USD 0 vs est 0.03 ▼ miss |
| 2025-07-31 | USD -0.01 vs est 0.03 ▼ miss |
| 2025-04-30 | USD 0 vs est 0.03 ▼ miss |
Source: Nexqual, June 10, 2026 at 04:03 UTC.
Financials & Fundamentals (PBSV)
| Total Revenue | $8.82M |
|---|---|
| Revenue Growth (YoY) | -7.10% |
| Gross Margin | +32.46% |
| Operating Margin | -4.12% |
| Profit Margin | -0.86% |
| ROE | -0.69% |
| Current Ratio | 4.03 |
| Total Cash | $10.56M |
| Total Debt | $0 |
| Free Cash Flow | $226,071 |
Source: Nexqual, June 10, 2026 at 04:03 UTC.
Financial Health Score (PBSV)
Nexqual rates Pharma-Bio Serv, Inc.'s overall financial health "Weak" across five dimensions, as of June 10, 2026 at 04:03 UTC.
| Growth | Weak — Revenue -5% YoY (annual), declining |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Mixed — $11M cash, no debt |
| Cash Flow | Mixed — FCF $226K, slim 2.5% margin |
| Efficiency | Critical — ROE -1%, ROA -2.7% |
Ownership (PBSV)
| Insider Ownership | +64.94% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 22.90M |
| Float | 8.37M |
Source: Nexqual, June 10, 2026 at 04:03 UTC.
Leadership (PBSV)
Pharma-Bio Serv, Inc. is led by Victor Sanchez (age 54), CEO, President & President of European Operations, per Nexqual as of June 10, 2026 at 04:03 UTC.
| CEO, President & President of European Operations | Victor Sanchez (age 54) |
|---|---|
| CFO, VP of Finance & Administration and Secretary | Pedro J. Lasanta (age 65) |
From Pharma-Bio Serv, Inc.'s Latest SEC 10-K Filing (filed 2026-01-29)
Key Strengths & Strategy (as disclosed to the SEC)
- Pharma-Bio Serv, Inc. operates as a regulatory affair, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally.
- The company offers a broad range of technical compliance consulting services, including regulatory affairs, quality assurance, compliance, technology transfer, validation, engineering, project management, and process support.
- It serves pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PFHO | Pacific Health Care Organizatio | USD 0.91 | ▼ 18.02% |
| GLGI | Greystone Logistics, Inc. | USD 0.2 | ▼ 6.9% |
| NROM | Noble Roman's, Inc. | USD 0.49 | ▲ 40% |
| IEHC | IEH Corp. | USD 19.83 | ▲ 1.41% |
| SCND | Scientific Industries, Inc. | USD 0.7 | ▼ 6.04% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 04:03 UTC. This page is informational and not investment advice.